Table 1

Limitations to clinical translation of results from current experimental models of AF

  • Complexity of the clinical condition

  • Range of clinical presentations and underlying mechanisms

  • Variation in features over the life-course

  • Complexity of human condition, often involving multiple pathologies and conditions

  • Limitations of experimental paradigms

  • Limitations imposed by species differences in cardiac electrophysiology, heart size, availability etc.

  • Lack of models manifesting spontaneous AF

  • Complications due to anaesthesia, need for chronic instrumentation or acute surgery for arrhythmia susceptibility testing

  • Technical challenges and patient variability for human atrial-biopsy studies

  • Often immature and incompletely controlled IPSC-CM phenotype

  • Problems extrapolating from animal models to humans

  • Animal models lack complexity of human condition

  • Differences in ion-channel properties, anatomy, structure etc.

  • Intrinsic limitations of the model systems studied

  • Each experimental system extrapolates with restrictions to specific human scenarios and AF phenotypes

  • Inference to clinical pathophysiology must be careful and guarded

  • Complexity of the clinical condition

  • Range of clinical presentations and underlying mechanisms

  • Variation in features over the life-course

  • Complexity of human condition, often involving multiple pathologies and conditions

  • Limitations of experimental paradigms

  • Limitations imposed by species differences in cardiac electrophysiology, heart size, availability etc.

  • Lack of models manifesting spontaneous AF

  • Complications due to anaesthesia, need for chronic instrumentation or acute surgery for arrhythmia susceptibility testing

  • Technical challenges and patient variability for human atrial-biopsy studies

  • Often immature and incompletely controlled IPSC-CM phenotype

  • Problems extrapolating from animal models to humans

  • Animal models lack complexity of human condition

  • Differences in ion-channel properties, anatomy, structure etc.

  • Intrinsic limitations of the model systems studied

  • Each experimental system extrapolates with restrictions to specific human scenarios and AF phenotypes

  • Inference to clinical pathophysiology must be careful and guarded

Table 1

Limitations to clinical translation of results from current experimental models of AF

  • Complexity of the clinical condition

  • Range of clinical presentations and underlying mechanisms

  • Variation in features over the life-course

  • Complexity of human condition, often involving multiple pathologies and conditions

  • Limitations of experimental paradigms

  • Limitations imposed by species differences in cardiac electrophysiology, heart size, availability etc.

  • Lack of models manifesting spontaneous AF

  • Complications due to anaesthesia, need for chronic instrumentation or acute surgery for arrhythmia susceptibility testing

  • Technical challenges and patient variability for human atrial-biopsy studies

  • Often immature and incompletely controlled IPSC-CM phenotype

  • Problems extrapolating from animal models to humans

  • Animal models lack complexity of human condition

  • Differences in ion-channel properties, anatomy, structure etc.

  • Intrinsic limitations of the model systems studied

  • Each experimental system extrapolates with restrictions to specific human scenarios and AF phenotypes

  • Inference to clinical pathophysiology must be careful and guarded

  • Complexity of the clinical condition

  • Range of clinical presentations and underlying mechanisms

  • Variation in features over the life-course

  • Complexity of human condition, often involving multiple pathologies and conditions

  • Limitations of experimental paradigms

  • Limitations imposed by species differences in cardiac electrophysiology, heart size, availability etc.

  • Lack of models manifesting spontaneous AF

  • Complications due to anaesthesia, need for chronic instrumentation or acute surgery for arrhythmia susceptibility testing

  • Technical challenges and patient variability for human atrial-biopsy studies

  • Often immature and incompletely controlled IPSC-CM phenotype

  • Problems extrapolating from animal models to humans

  • Animal models lack complexity of human condition

  • Differences in ion-channel properties, anatomy, structure etc.

  • Intrinsic limitations of the model systems studied

  • Each experimental system extrapolates with restrictions to specific human scenarios and AF phenotypes

  • Inference to clinical pathophysiology must be careful and guarded

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close